Conditions: Herpes Labialis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1727
Healthy volunteers: no

Brief summary:
To demonstrate the efficacy of a single dose of acyclovir Lauriad® 50mg muco-adhesive buccal tablet versus a single dose of matching placebo on the primary vesicular lesion of cold sore.

Detailed description:

Arms:
arm 1: Acyclovir Lauriad 50mg arm 2: None

Interventions: intervention 1: Acyclovir Lauriad intervention 2: Placebo
Intervention descriptions: intervention 1: 50 mg muco-adhesive buccal tablets, single application on the gum intervention 2: 50 mg muco-adhesive buccal tablets, single application on the gum

Protocol document: